Department of Pediatrics, Kafkas University School of Medicine, Kars, Turkey.
Division of Pulmonary & Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
J Clin Sleep Med. 2022 Apr 1;18(4):1021-1026. doi: 10.5664/jcsm.9790.
Positive airway pressure (PAP) is the second line of treatment for obstructive sleep apnea syndrome in children. It is common practice following initiation of PAP to perform repeat titration polysomnography to re-evaluate the patient's therapeutic pressure; however, data supporting this practice are lacking. We hypothesized that repeat PAP titration would result in significant setting changes in children with obstructive sleep apnea syndrome.
We retrospectively analyzed demographic, polysomnographic, and PAP data of children with obstructive sleep apnea syndrome aged 0-18 years who were initiated on PAP and underwent 2 titration studies over a 2-year period. PAP mode and recommended pressure differences between the 2 titrations were compared.
64 children met inclusion criteria. The median (interquartile range) baseline obstructive apnea-hypopnea index and SpO nadir were 14.8 (8.7-32.7) events/h and 88.5% (85-92%), respectively. The mean differences in obstructive apnea-hypopnea index, SpO nadir, and % total sleep time with SpO < 90% between both titrations were negligible, including children with obesity, adenotonsillar hypertrophy, and trisomy 21. Additionally, there was no significant difference in mean PAP pressure between 2 separate titration studies for those on continuous PAP or bilevel PAP.
Overall, repeat PAP titration in children with obstructive sleep apnea syndrome within the timeframe here described did not result in significant changes in PAP mode, continuous PAP pressure, or obstructive apnea-hypopnea index. Based on these data, repeat PAP titration within 2 years of an initial titration does not appear to be necessary.
Yendur O, Feld L, Miranda-Schaeubinger M, et al. Clinical utility of repeated positive airway pressure titrations in children with obstructive sleep apnea syndrome. . 2022;18(4):1021-1026.
气道正压通气(PAP)是儿童阻塞性睡眠呼吸暂停综合征的二线治疗方法。在开始使用 PAP 后,通常会进行重复压力滴定多导睡眠图以重新评估患者的治疗压力;然而,缺乏支持这种做法的数据。我们假设在患有阻塞性睡眠呼吸暂停综合征的儿童中,重复 PAP 滴定会导致治疗压力的显著变化。
我们回顾性分析了在 2 年内接受 2 次滴定研究的 0-18 岁患有阻塞性睡眠呼吸暂停综合征的儿童的人口统计学、多导睡眠图和 PAP 数据。比较了 2 次滴定之间的 PAP 模式和建议的压力差异。
64 名儿童符合纳入标准。基线阻塞性呼吸暂停低通气指数和 SpO2 最低点的中位数(四分位距)分别为 14.8(8.7-32.7)次/小时和 88.5%(85-92%)。2 次滴定之间的阻塞性呼吸暂停低通气指数、SpO2 最低点和 %总睡眠时间 SpO2<90%的平均值差异可以忽略不计,包括肥胖、腺样体扁桃体肥大和 21 三体的儿童。此外,对于接受持续 PAP 或双水平 PAP 的儿童,2 次单独滴定之间的平均 PAP 压力没有显著差异。
总体而言,在本研究中描述的时间范围内,患有阻塞性睡眠呼吸暂停综合征的儿童重复 PAP 滴定并未导致 PAP 模式、持续 PAP 压力或阻塞性呼吸暂停低通气指数发生显著变化。基于这些数据,在初始滴定后 2 年内重复 PAP 滴定似乎没有必要。